ACERNA
AceRNA contributes to regenerative medicine and drug discovery through the discovery of novel miRNA functions. It began operation in April 2018, with its headquarters in Kyoto in Japan.
ACERNA
Social Links:
Industry:
Biopharma Biotechnology Genetics Health Care Life Science Therapeutics
Founded:
2018-04-01
Address:
Kyoto, Kyoto, Japan
Country:
Japan
Website Url:
http://www.acernatec.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
282.02 M JPY
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Current Employees Featured
Founder
Investors List
Hirofumi Miki
Hirofumi Miki investment in Angel Round - AceRNA
Hidetoshi Takano
Hidetoshi Takano investment in Angel Round - AceRNA
SMBC Venture Capital
SMBC Venture Capital investment in Series A - AceRNA
Kyoto University Innovation Capital
Kyoto University Innovation Capital investment in Series A - AceRNA
Kyoto University Innovation Capital
Kyoto University Innovation Capital investment in Seed Round - AceRNA
Official Site Inspections
http://www.acernatec.com
- Host name: server-3-171-76-121.iad89.r.cloudfront.net
- IP address: 3.171.76.121
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "AceRNA"
aceRNA Technologies - Crunchbase Company Profile & Funding
Organization. aceRNA Technologies . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; …See details»
News - aceRNA
We are a Biotech-startup focused on developing novel genetic therapies. Our goal is to develop novel therapies that target only cells causing a disease, with minimal patient burden.See details»
aceRNA Technologies Company Profile 2024: …
AceRNA Technologies General Information Description. Developer of a novel drug designed to provide one class of gene-regulatory elements that control. The company specializes in regenerative medicine through the discovery of novel …See details»
aceRNA Technologies - Overview, News & Similar companies
Who is aceRNA Technologies. aceRNA Technologies Co., Ltd. is a biotech startup established in 2018 based on RNA design technology developed in synthetic RNA biology research b y Prof. …See details»
aceRNA Technologies - LinkedIn
AceRNA Technologies Co., Ltd. is a biotech startup established in 2018 based on RNA design technology developed in synthetic RNA biology research by Prof. Hirohide Saito at Kyoto …See details»
ACERNA TECHNOLOGIES, CO., LTD. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ACERNA TECHNOLOGIES, CO., LTD. of KYOTO, KYOTO. Get the latest business insights from Dun & …See details»
aceRNA Technologies Co., Ltd. - VentureRadar
Website: https://acernatec.com/ Develops targeted mRNA therapeutics using innovative RNA switch technology, collaborating with industry leaders to advance precision ...See details»
aceRNA Technologies - Craft
AceRNA Technologies has 1 employees at their 1 location and $72.05 k in total funding,. See insights on aceRNA Technologies including office locations, competitors, revenue, financials, …See details»
Acerna Technologies
Thinking about "the Cloud"? Acerna Technologies can help you navigate the confusing fog of cloud services. We provide help in creating and migrating to various providers whether you are …See details»
aceRNA Technologies Co., Ltd. - VentureRadar
Website: https://acernatec.com/ aceRNA Technologies is contributing to regenerative medicine and drug discovery through discovery of new functions of miRNA.See details»
aceRNA Technologies Co., Ltd. - Sinodo Surgical Sutures
AceRNA Technologies is developing targeted mRNA medicines that enable control of therapeutic transgene expression in a cell-specific manner. Our microRNA-based expression control …See details»
aceRNA Technologies Co., Ltd. | Global Startup Acceleration …
AceRNA Technologies is developing "targeted mRNA medicine” that enables control of therapeutic transgene expression in a cell-type and -state specific manner.See details»
株式会社aceRNA Technologiesの会社情報と資金調達 | NIKKEI …
【NIKKEI COMPASS】株式会社aceRNA Technologiesは、京都大学iPS細胞研究所の齊藤博英教授らが発明した「RNAスイッチ」を基盤に研究開発を行っている企業。See details»
Acerna Inc Company Profile | Markham, ON, Canada | Competitors ...
Find company research, competitor information, contact details & financial data for Acerna Inc of Markham, ON. Get the latest business insights from Dun & Bradstreet.See details»
Partnership - aceRNA
MRNA-based gene therapy: Design and development of mRNA-based drugs using RNA Switch technology: Cell therapy: Development of Switches that regulate the expression of …See details»
株式会社aceRNA Technologiesの会社概要｜ミドルの転職
転職成功者続出！株式会社aceRNA Technologiesなどの人材紹介会社が保有する転職・求人情報が満載。800万円以上の高年収、管理職・スペシャリストの求人、株式会社aceRNA …See details»
第三者割当増資のお知らせ - aceRNA
株式会社aceRNA Technologies(本社：京都市左京区、代表取締役：須川 史啓)は、DCIパートナーズ株式会社（本社：東京都千代田区、代表取締役社長：成田 宏紀）、東京大学協創プ …See details»
aceRNA Technologies Secures 960 million JPY Series B to develop ...
May 7, 2024 aceRNA Technologies, a Kyoto-based biotechnology company developing novel engineered mRNA therapeutics using its proprietary technologies such as “RNA Switch™︎”, …See details»
News - aceRNA
弊社とjcrファーマ株式会社との共同研究に関する記事が日経バイオテクに掲載されました。 2021年4月1日に当ホームページ上でプレスリリースを発表したjcrファーマ株式会社との共 …See details»
Technology - aceRNA
With the development of molecular biology, we understood that changes in sequence and expression of genes can cause several diseases. As such, from approaches targeting …See details»